Filing Flows › Fennec Pharmaceuticals (FENC) › Next earnings date
Fennec Pharmaceuticals (FENC) earnings on Nov 12, 2026: what to expect
Fennec Pharmaceuticals (FENC) is expected to report earnings on Nov 12, 2026, in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of $0.11 ($0.06 to $0.16, 5 estimates) on revenue of $18.9M, against −$0.02 and $12.5M a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 75% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.02 on revenue of $22.9M, against the analysts' $0.11.
The last report
Fennec Pharmaceuticals reported revenue of $17.9M for the second quarter 2026 (+85% Y/Y), net earnings $2.0M: PEDMARK product sales, net $17.2M, Other revenue $710K. How it makes money → · Every quarter →
Fennec Pharmaceuticals' latest quarter
Fennec Pharmaceuticals, Q2 2026: revenue $17.9M (+85% year over year), operating margin 9.7%, net earnings $2.0M, operating cash flow $50K. The chart follows the revenue to costs, profit and cash.
Questions
When does FENC report earnings?
Fennec Pharmaceuticals is expected to report on Nov 12, 2026.
What are analysts expecting from Fennec Pharmaceuticals?
EPS of $0.11 and revenue of $18.9M for the quarter.
Does Fennec Pharmaceuticals usually beat earnings?
It beat the consensus EPS estimate in 75% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.